Asston Pharmaceuticals’ IPO, priced at Rs 115–123 per share, has seen strong investor interest, with a GMP of Rs 30 ahead of its July 16 BSE SME listing. The Rs 27.56 crore issue is entirely a fresh offer, aimed at funding machinery, working capital, and debt repayment. The company posted a 218% YoY profit jump in FY25.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets